Harrow Inc (HROW)
43.88
+1.44
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
43.58
-0.30
(-0.68%)
After-Hours: 20:00
Harrow Max Drawdown (5Y): 71.15% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 71.15% |
| September 30, 2024 | 71.15% |
| August 31, 2024 | 71.15% |
| July 31, 2024 | 71.15% |
| June 30, 2024 | 71.15% |
| May 31, 2024 | 71.15% |
| April 30, 2024 | 71.15% |
| March 31, 2024 | 71.15% |
| February 29, 2024 | 71.15% |
| January 31, 2024 | 71.15% |
| December 31, 2023 | 71.15% |
| November 30, 2023 | 71.15% |
| October 31, 2023 | 59.77% |
| September 30, 2023 | 74.94% |
| August 31, 2023 | 74.94% |
| July 31, 2023 | 74.94% |
| June 30, 2023 | 75.61% |
| May 31, 2023 | 77.04% |
| April 30, 2023 | 78.60% |
| March 31, 2023 | 82.80% |
| February 28, 2023 | 82.80% |
| January 31, 2023 | 84.40% |
| December 31, 2022 | 84.40% |
| November 30, 2022 | 84.60% |
| October 31, 2022 | 89.08% |
| Date | Value |
|---|---|
| September 30, 2022 | 89.08% |
| August 31, 2022 | 89.60% |
| July 31, 2022 | 89.60% |
| June 30, 2022 | 89.60% |
| May 31, 2022 | 89.60% |
| April 30, 2022 | 89.60% |
| March 31, 2022 | 89.60% |
| February 28, 2022 | 89.60% |
| January 31, 2022 | 89.60% |
| December 31, 2021 | 89.60% |
| November 30, 2021 | 89.60% |
| October 31, 2021 | 89.60% |
| September 30, 2021 | 89.60% |
| August 31, 2021 | 89.60% |
| July 31, 2021 | 89.60% |
| June 30, 2021 | 89.60% |
| May 31, 2021 | 89.60% |
| April 30, 2021 | 89.60% |
| March 31, 2021 | 89.60% |
| February 28, 2021 | 89.60% |
| January 31, 2021 | 89.60% |
| December 31, 2020 | 89.60% |
| November 30, 2020 | 89.60% |
| October 31, 2020 | 89.60% |
| September 30, 2020 | 89.60% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
59.77%
Minimum
Oct 2023
89.60%
Maximum
Nov 2019
83.55%
Average
89.60%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Calidi Biotherapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 43.01 |
| Beta (5Y) | 0.7630 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 73.67% |
| Historical Sharpe Ratio (5Y) | 0.7176 |
| Historical Sortino (5Y) | 1.647 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.28% |